Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

First use of nView medical’s novel 3D imaging technology in pediatric spine surgery


We anticipate this improved precision will lead to better outcomes and added value to what we do for our patients.

Children’s National Hospital today performed the first surgical use of breakthrough medical imaging technology designed specifically for kids. The innovation, insta-3D™ imaging from company nView medical, is designed to make 3D images available in the operating room quickly and safely. The 3D images provide surgeons with better visualization, allowing them to continue improving patient care and outcomes.

Matthew Oetgen, M.D., division chief of Orthopaedic Surgery at Children’s National, is overseeing the first use of this 3D imaging technology in orthopaedic procedures.

“Having a technology like this available in the operating room will potentially help make our surgeries even more precise with 3D imaging available quickly,” says Dr. Oetgen. “We anticipate this improved precision will lead to better outcomes and added value to what we do for our patients.”

Cristian Atria, nView medical’s CEO, commented for the first case.

“Seeing our imaging technology provide critical information during a kid’s surgery reminds us what the purpose of nView medical is all about,” says Cristian. “I would like to thank the surgeons, our backers, the team, and our clinical partners for making this first surgery a success. I couldn’t be more enthusiastic for what’s ahead!”

The potential of nView medical’s insta-3D™ imaging is especially exciting for Children’s National as nView medical is a 2019 Winner of the National Capital Consortium for Pediatric Device Innovation (NCC-PDI) competition “Make Your Medical Device Pitch for Kids!” NCC-PDI is led by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National and the A. James Clark School of Engineering at the University of Maryland with support from partners MedTech Innovator, BioHealth Innovation, and design firm Archimedic.

NCC-PDI is one of five members in the FDA’s Pediatric Device Consortia Grant Program created to support the development and commercialization of medical devices for children in areas of critical need where innovation can significantly improve children’s health care.

“Children deserve to benefit from our most advanced medical technologies and we know that improvements in pediatric care can make a positive difference over the lifetime of a child,” says Kolaleh Eskandanian, Ph.D., M.B.A, P.M.P, vice president and chief innovation officer at Children’s National and principal investigator of NCC-PDI. “Pediatric hospitals must lead the way in supporting innovation for children’s care. That’s why, through NCC-PDI and our innovation institute, Children’s National helps to provide promising new pediatric devices with resources and expertise that support their journey to the market.”

–

About nView medical:

nView medical, based in Salt Lake City, UT, is a startup whose mission is to make surgery safer, faster, and consistently accurate. nView develops imaging systems, bringing breakthrough AI solutions for image creation, image processing, and image visualization to surgery and interventional radiology. nView medical backers include the National Science Foundation (NSF), the National Institutes of Health (NIH), the State Of Utah, the National Capital Consortium for Pediatric Device Innovation, MedTech Innovator, HealthTech Arkansas, Dr. Kevin Foley, MD, and Fusion Fund (Palo Alto, CA).

About Children’s National Hospital

Children’s National Hospital, based in Washington, D.C., celebrates 150 years of pediatric care, research and commitment to community. Volunteers opened the hospital in 1870 with 12 beds for children displaced after the Civil War. Today, 150 years stronger, it is among the nation’s top 10 children’s hospitals. It is ranked No. 1 for newborn care for the fourth straight year and ranked in all specialties evaluated by U.S. News & World Report. Children’s National is transforming pediatric medicine for all children. In 2020, construction will be complete on the Children’s National Research & Innovation Campus, the first in the nation dedicated to pediatric research. Children’s National has been designated twice as a Magnet® hospital, demonstrating the highest standards of nursing and patient care delivery. This pediatric academic health system offers expert care through a convenient, community-based primary care network and specialty outpatient centers in the D.C., metropolitan area, including the Maryland and Northern Virginia suburbs. Children’s National is home to the Children’s National Research Institute and Sheikh Zayed Institute for Pediatric Surgical Innovation and is the nation’s seventh-highest NIH-funded children’s hospital. It is recognized for its expertise and innovation in pediatric care and as a strong voice for children through advocacy at the local, regional and national levels.

Share article on social media or email:

MD Logic Health Introduces a New Nutritional Supplement to Support Healthy Brain Function, Focus, Concentration, and Clarity


We are very proud to introduce SmartBRAIN by MD Logic Health as the newest in our line of cognitive support supplements.

MD Logic Wellness, last week announced that it has launched SmartBRAIN by MD Logic Health, a nutritional supplement featuring Acetyl-L-Carnitine, Phosphatidylserine, and Alpha GPC. It is known that as we age, our mental performance sees a noticeable decline in its normal functioning. While growing evidence and studies have revealed that exercise, genetics, and other lifestyle factors may impact our brain health and mental performance, new research reveals that nutrition can play a positive role in supporting healthy brain function, focus, concentration, and clarity. SmartBRAIN formula includes Phosphatidylserine, a phospholipid abundant in the brain. Phosphatidylserine improves neuron survival and supports the mechanisms needed for the formation of memories and learning.

Scott Emmens, Co-Founder of MD Logic Wellness commented, “As a busy entrepreneur, husband and father being able to maintain focus and recall throughout a long day is essential to maximize business and personal success. SmartBRAIN’s stimulant-free formula allows me to seamlessly pivot from project to project without the jitters caffeine can cause. SmartBRAIN supports my natural neurotransmitters to keep me sharp and supplies Phosphatidylserine to support memory. We are very proud to introduce SmartBRAIN by MD Logic Health as the newest in our line of cognitive support supplements.”

All MD Logic Health products are manufactured in the USA. We source only the purest and most effective ingredients which are quarantined and tested to meet approved specifications prior to being released for use. We strive to create effective and high-quality products based on clinical studies and scientific research. We are committed to delivering premium supplements to support a healthy lifestyle. Each MD Logic Health supplement is formulated with a specific purpose in mind. We believe that overall health and wellness can be improved by supplementing a healthy diet. MD Logic Health provides options that are gluten-free, vegetarian, dairy, and GMO-free with no artificial colors or flavors. For more information about SmartBRAIN and our other products please visit us at https://www.mdlogichealth.com or call 877-629-8711.

About MD Logic Wellness

MD Logic Health was created and founded by passionate health and wellness advocates. Our mantra is Spirit, Mind, Body, and Planet. Our quality is at the core of who we are and what we offer. Our purity and efficacy come from the superior ingredients used in every MD Logic Health product. Individual dietary and non-dietary ingredients are tested for identity, strength, purity, and composition compliance to ensure maximum effectiveness prior to use.

We currently have three distinct product lines to create a 360-degree ecosystem to link all potential customers. The Professional Line is sold exclusively to Health Care Providers, the MD Logic Health line is sold directly to consumers and the Essential line is sold to retail stores for core nutritional products.

“We believe health and well-being is the foundation to achieve your best life. Our mission is to connect our community to their health through superior dietary supplements, education, and health professional guidance. We believe our customers deserve the highest quality products, service, and support. MD Logic Health connects health care professionals and patients in their mutual pursuit of optimal wellbeing.”

Availability

SmartBRAIN by MD Logic Health is now available online at our website https://www.mdlogichealth.com and on Amazon at https://www.amazon.com/MD-Logic-Health-SmartBRAIN/dp/B08NXX36BQ/

Contact

Jyoti Hardat, Director of Marketing

jhardat@mdlogichealth.com

+1(877) 629-8711 x700

Share article on social media or email:

Cranberry Peak announces strategic partnership with DigitalOne to deploy advanced imaging clinical decision support (CDS) service for healthcare providers


The technical integration between our CDS service and DigitalOne platform was extremely smooth. DigitalOne’s engineering team is top notch and has completed the technical integration within 3 weeks.

Cranberry Peak, a leading provider of AI, conversational interfaces and clinical decision support (CDS) technology announced today that it has formed a strategic partnership with DigitalOne. Cranberry Peak’s clinical decision service, ezCDS has been integrated with DigitalOne’s Orders Communicator, and is available to more than 100,000 providers currently connected through the DigitalOne Platform.

ezCDS is a CMS-qualified clinical decision support mechanism (CDSM) for the Appropriate Use Criteria (AUC) Program, supporting the implementation of Protecting Access to Medicare Act of 2014 (PAMA). Specifically, under this program, ordering physicians will be required to consult a CDSM for advanced diagnostic imaging orders. In addition to facilitating evidence-based medicine and standards of care at the point of care, ezCDS is also transforming user experience in healthcare and reducing physician burnout by introducing the first AI digital assistant serving ordering physicians, with voice and conversational interface. ezCDS supports modern interoperability standards with FHIR and CDS Hooks state of the art technology.

“With the integration of ezCDS into the DigitalOne Platform, our clients now have an intuitive solution to address CDS requirements that fits seamlessly into their workflow,” said N Gulati, Sr Partner at DigitalOne. “With this partnership, imaging providers are now able to offer an easy to use solution to their referrer community to perform CDS consultations for advanced imaging orders across all referral channels even if the referring EMR doesn’t offer CDS capability natively.”

Cranberry Peak’s Founder and CEO, Neculai Archip, PhD, MBA, said, “We have been working with the DigitalOne team for a while, and we are impressed by their effectiveness. In particular, the technical integration between our CDS service and DigitalOne platform was extremely smooth. DigitalOne’s engineering team is top notch and has completed the technical integration within 3 weeks.”

“Our companies are continuously optimizing our combined solution to best serve our users. Therefore, we are confident that this partnership will be successful for healthcare providers and positively impact the healthcare industry,“ Dr. Archip goes on to say.

Visit Cranberry Peak at https://www.cranberrypeak.com and DigitalOne at http://www.digitalonereports.net to learn more about this new partnership and how it can help you meet both current and future healthcare demands. During the week of November 30, 2020, Cranberry Peak is hosting online presentations on its website.

About Cranberry Peak

Cambridge, MA-based Cranberry Peak Corp. is a leader in AI, conversational interfaces and clinical decision support technology. In addition to enabling evidence-based medicine and standards of care, at the point of care, with the goal of improving healthcare delivery, Cranberry Peak is also aiming at reducing physician burnout.

For more information https://www.cranberrypeak.com or email contact@cranberrypeak.com

About DigitalOne

DigitalOne offers leading Interoperability Solutions that help Imaging Providers better serve their referring community while eliminating the time and expense associated with building point-to-point interfaces. The DigitalOne Platform that includes Orders Caddy, Desktop Delivery, EMRConnect, Zero Footprint Image Viewer, Orders Communicator and Patient Portal, deliver multiple convenient channels for referring providers to submit referrals and receive timely results into their EMR – securely, reliably and effectively.    

For more information https://www.digitalonereports.net or email info@digitalonereports.net

Share article on social media or email:

Capio Welcomes Jim Pender as Vice President, National Accounts


Capio is pleased to welcome Jim Pender in the role of Vice President, National Accounts. Jim joins us with over 30 years’ experience within the healthcare receivables management industry. Most recently, Jim served as the Vice President of Sales and Marketing for Medi-Centrix. Jim will be responsible for identifying new opportunities and supporting our existing national provider clients.

Jim brings a wealth of experience and knowledge to this role. Prior to joining Capio, he held leadership positions at EOS, McKesson, and Outsourcing Solutions, Inc. He began his career in operations at OSI prior to advancing into client management and sales roles.

“Jim is joining our team at Capio during a unique time. Despite the challenges of Covid-19, we are witnessing rapid growth as healthcare providers continue to rely on Capio to assist in their cash acceleration efforts,” noted Dan Kutchel, Capio’s Chief Sales officer. He added, “Our team is the best in the industry, and we are thrilled to have Jim join us. Jim’s integrity, vast knowledge of the healthcare revenue cycle, deep personal connections, and past successes will allow him to excel in his new role.”

Jim is active in several professional associations including Healthcare Finance Management Association (HFMA) on both a national and local level. Jim is also a member American Association of Healthcare Administrative Management, Medical Group Management Association, American Medical Group Association, Community Oncology Alliance and American Society of Anesthesiologists.

About Capio

Capio assists healthcare providers and physician organizations increase cashflow, while also lowering their bad debt expense. To date, Capio has acquired and provided consumer services with over $30B in patient accounts receivable, via partnerships alongside more than 450 provider clients across the United States. To learn more about Capio, please visit http://www.capiopfw.com

Share article on social media or email:

Rollis Fontenot III of HR Maximizer Inc accepted into Forbes Business Council


Profile picture of Rollis

Rollis Fontenot III, president of HR Maximizer Inc

I am very excited about being a part of this global community of business leaders who are looking to offer their expertise to help others grow. In this way, the rising tide will lift all boats, thereby helping all of us attain our individual goals.

Rollis Fontenot III of HR Maximizer Inc accepted into Forbes Business Council

Forbes Business Council Is an Invitation-Only Community for Successful Business Owners and Leaders

Rollis Fontenot III, president & founder of HR Maximizer Inc, a subscription based recruitment services firm serving clients nationwide, has been accepted into the Forbes Business Council, the foremost growth and networking organization for successful business owners and leaders worldwide.

Rollis Fontenot III was vetted and selected by a review committee based on the depth and diversity of his experience. Criteria for acceptance include a track record of successfully impacting business growth metrics, as well as personal and professional achievements and honors.

“We are honored to welcome Rollis Fontenot III into the community,” said Scott Gerber, founder of Forbes Councils, the collective that includes Forbes Business Council. “Our mission with Forbes Councils is to bring together proven leaders from every industry, creating a curated, social capital-driven network that helps every member grow professionally and make an even greater impact on the business world.”

As an accepted member of the Council, Rollis has access to a variety of exclusive opportunities designed to help his reach peak professional influence. he will connect and collaborate with other respected local leaders in a private forum and at members-only events. Rollis will also be invited to work with a professional editorial team to share his expert insights in original business articles on Forbes.com, and to contribute to published Q&A panels alongside other experts.

Finally, Rollis will benefit from exclusive access to vetted business service partners, membership-branded marketing collateral, and the high-touch support of the Forbes Councils member concierge team.

“I am very excited about being a part of this global community of business leaders who are looking to offer their expertise to help others grow. In this way, the rising tide will lift all boats, thereby helping all of us attain our individual goals. I look forward to this opportunity for us to make valuable contributions to this group as we grow together.”

ABOUT FORBES COUNCILS

Forbes Councils is a collective of invitation-only communities created in partnership with Forbes and the expert community builders who founded Young Entrepreneur Council (YEC). In Forbes Councils, exceptional business owners and leaders come together with the people and resources that can help them thrive.

To learn more about Forbes Councils, visit forbescouncils.com.

Share article on social media or email:

New Immune Max Mints from Enzymedica Use Innovative Technology to Deliver Unique Immune Supporting Probiotic Strain in a Great Tasting Quick Melt Mint


mints, candy, probiotics, new supplements, immunity, immune system

These new mints dissolve in the mouth to deliver 12 billion cells of HK Lactobacillus plantarum L-137, a unique probiotic strain that is clinically studied to support immune and respiratory health.*

Enzymedica®, a Florida-based company that produces high quality natural digestive products, announces the launch of its innovative Immune Max™ Immuno-Biotic Defense Mints. These great tasting and refreshing mints dissolve in the mouth to deliver 12 billion cells of HK Lactobacillus plantarum L-137, also known as of Immuno-LP20®, a unique probiotic strain that is clinically studied to support immune and respiratory health.* Stress and fatigue can easily lower immunity, and this formula helps boost the immune and digestive systems by increasing natural killer T-cell activity, which are on the front lines to help protect against seasonal threats.*

The probiotic strain L-137 was originally discovered by Japanese immunologists, working at the prestigious Medical Institute of Bioregulation at Kyushu University, who were testing new substances to improve key markers for immune health. By fermenting fish with lactic acid bacteria to create Narezushi, a precursor to modern sushi, the scientists were able to isolate a novel lactic acid bacterium. It became known as probiotic L-137 and it demonstrated beneficial immune boosting properties, made even more robust through a heat-treatment process that converts the strain to HK L-137. *

The heat-treatment process that converts L-137 to HK L-137 locks the structure of the bacterial cells to their shape at the highest point of activity. This allows the beneficial bacterial cells to work in a human’s gastric acid, while also promoting the ability for the probiotic bacterial cells to interact with immune cells in the intestine.* The beneficial properties of HK L-137 are most associated with Lipoteichoic acids, components of the cell wall of the probiotic bacterium. These acids provide nutrition for the body’s immune system by boosting the production of interleukin-12, a substance secreted by immune cells that strengthens the body’s overall immune defense system. *

Following its initial discovery, human clinical studies have demonstrated that HK L-137 benefits the immune system, respiratory health, and overall quality of life.* Each package of Enzymedica’s Immune Max Mints contains 30 fast-acting quick melt mints for $19.99 and can be purchased at https://enzymedica.com/products/immune-max-immuno-biotic-defense-mints?variant=32531305889841.

About Enzymedica

Enzymedica is a Florida-based, natural digestive health company since 1998 that sells to over 30,000 stores worldwide and online. Its top-selling enzyme brand is No. 1 in America. In addition to high quality products, Enzymedica also is dedicated to its People & Planet initiative, which is a core pillar within the company’s mission – to leave a legacy that will make the world a better place. The company has received more than 50 industry awards including multiple Better Nutrition Magazine’s People’s Choice Awards, many Best of Supplements Awards and numerous VITY and Nexty Awards. Visit https://enzymedica.com/ for more information.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Media Contact

Ria Romano, Partner

RPR Public Relations, Inc.

Tel. 786-290-6413

Share article on social media or email:

Mindray to Showcase Leading-Edge Ultrasound Systems Through Virtual Reality Experience at RSNA


Mindray Logo

Mindray is a leading global developer, manufacturer, and supplier of medical devices whose mission is to advance medical technologies to make healthcare more accessible.

Our team is determined to ensure frontline heroes and their patients have the tools they need; and while many things have changed in 2020, Mindray’s vision has not – we will continue to drive our vision of better healthcare for all forward.

Mindray, a global leader in the development of healthcare technologies, will attend the Radiological Society of North America’s (RSNA) 106th Scientific Assembly and Annual Meeting, November 29 – December 5. During this year’s virtual event, Mindray will highlight their comprehensive portfolio of Radiology ultrasound machines through an immersive and interactive virtual reality (VR) platform.

Throughout the last few years, Mindray has achieved consistent growth in a highly competitive marketplace. Due to an incredible value proposition, advanced technologies and industry-leading warranty, Mindray North America was one of only three companies to achieve double-digit growth in their Radiology ultrasound division in 2019. In addition, Mindray was recently awarded a contract in the ultrasound category for the Pediatric Program at Vizient®, and excelled in landing strategic partnerships with the top 10 hospitals in the United States. Mindray continues to provide new and improved ways to enhance patient care and manage costs without sacrificing quality.

“With COVID-19 challenging every aspect of healthcare and forcing many to rethink the ‘normal’ way of doing things, Mindray’s mission has become more important than ever before,” said Director of Marketing, Ultrasound, Maher Elhihi. “Mindray was founded on the dream of increasing access to outstanding care by providing accessible, relevant medical devices that exceed clinician’s expectations and needs. Our team is determined to ensure our frontline heroes and their patients have the tools they need; and while many things have changed in 2020, Mindray’s vision has not – we will continue to drive our vision of better healthcare for all forward.”

RSNA Virtual Reality Experience

Mindray will be debuting a one-of-a-kind VR experience at RSNA 2020. This virtual format provides healthcare professionals from around the world the opportunity to safely and conveniently explore Mindray’s latest solutions from the comfort of their home or office. Once an attendee enters the experience, they will be transported to a “Mindray Hospital” where they can explore Mindray’s Radiology ultrasound solutions in the departments in which they are used: Radiology/Imaging and Interventional Radiology. There is no special technology needed; the VR experience is desktop, laptop, tablet and mobile-friendly. Ultrasound team members and experts will be available throughout the duration of the exhibit to address any questions or comments from attendees.

Featured Systems Include:

•Resona 7 Ultrasound System: Mindray’s flagship Radiology Ultrasound System delivers crystal clear imaging capabilities with unrivaled detail resolution and image uniformity that is powered by the industry’s first virtual beamforming architecture, ZONE Sonography® Technology+ (ZST+).

•ZS3 Ultrasound System: Mindray’s ZS3 Ultrasound System is a smaller, lightweight System that combines premium performance and mobility for today’s demanding ultrasound environments. This unique portable System allows for rapid transition times resulting in increased exam efficiency and patient throughput.

•DC-90 Ultrasound System: Mindray’s DC-90 is a versatile, high-performing System designed for a comprehensive range of clinical applications. Exceptional image clarity, combined with advanced technology, aligns with the financial goals of a wide range of institutions.

Mindray’s comprehensive suite of Radiology ultrasound solutions includes an industry-leading five-year warranty and investment protection with software updates to keep customers at the forefront of ultrasound technology. Visit Mindray’s virtual exhibit through the RSNA website and learn more about the latest innovation and cutting-edge solutions.

About Mindray

Mindray is a leading developer, manufacturer, and supplier of medical device solutions and technologies used in healthcare facilities around the globe. We believe we can change lives by making the most advanced healthcare technology attainable for all. We do this by empowering healthcare professionals through innovative, high-value solutions that help create the next generation of life-saving tools across three primary business segments: patient monitoring and life support, in-vitro diagnostics, and medical imaging. Mindray maintains its global headquarters in Shenzhen, China; Mindray North America is headquartered in Mahwah, New Jersey. Our Ultrasound Innovation Center is located in San Jose, California with additional facilities in major international markets around the world. For more information, please visit http://www.mindray.com.

1.    Harder, B./U.S. News & World Report (July 28, 2020). 2020-21 Best Hospitals Honor Roll and Medical Specialties Rankings Retrieved from https://health.usnews.com/health-care/best-hospitals/articles/best-hospitals-honor-roll-and-overview

Share article on social media or email:

Jumpstart Foundry Announces Second Round of 2020 Portfolio Selections Including 5 Companies Nationwide


Jumpstart Foundry, a healthcare-focused private investment firm headquartered in Nashville, announced today its second round of 2020 portfolio selections. The Fall 2020 selection of portfolio companies consists of 5 healthcare startups chosen from a pool of more than 200 applicants, which brings the total number of seed-stage investments to 108 for the TN firm.

Ranked as one of the most active venture capital investors in Tennessee, Jumpstart Foundry annually makes 20-25 standard investments of $150,000 via convertible SAFE notes into innovative companies in the health space. These companies are expected to have a tremendous impact in the health domain while driving strong financial returns for Jumpstart’s investors.

“We received a record number of applications this year and were able to be incredibly selective in our approach,” said Eller Mallchok, Jumpstart Foundry’s Managing Director. “Of course, I was pleased with the quantity of applications, but the quality was also impressive. There is no lack of supply of healthcare innovation, and Jumpstart is here to help them grow.”

The Jumpstart Foundry Fall 2020 cohort of portfolio companies include various novel healthcare applications such as malnutrition diagnosis, behavioral health solutions, AI-powered labor management, and care management. All five companies will participate in a virtual onboarding orientation to connect with Jumpstart’s network of industry experts and will be indoctrinated into The Jumpstart Refinery, Jumpstart’s exclusive digital community, designed to connect the Jumpstart Foundry network and support growth acceleration.

“It has been an interesting and exciting year to be in venture capital – particularly in healthcare innovation. We are excited to welcome these new companies from diverse backgrounds across the country into the Jumpstart Foundry family,” said Jumpstart Foundry COO Dr. Brian Dougherty.

In a time of great uncertainty, Jumpstart Foundry remains committed to making investments that support healthcare innovation. The Nashville-based venture capital firm is excited to MAKE SOMETHING BETTER in health as they prepare to deploy more capital in 2021.

About Jumpstart Foundry:

Jumpstart Foundry is a seed-stage healthcare innovation fund with one goal: Make Something Better. Jumpstart Foundry invests $150K in 15-20 healthcare startups from around the country each year. Jumpstart then guides and supports entrepreneurs through a systemized, step-by-step process to help each business reach success. The JSF fund has over 100 companies in its portfolio and was reported as Tennessee’s most active venture capital firm in January 2020 by CB Insights.

For questions or additional information, please contact:

Richard Amoako

Content Marketing Manager | Jumpstart Foundry

richard@jsf.co

423-676-5282

Share article on social media or email:

EndoVigilant starts Pivotal Clinical Study to demonstrate Artificial Intelligence enabled assistance to gastroenterologists for detection of polyps during Colonoscopy


Dr. Shai Friedland, Professor of Medicine at Stanford University, the Principal Investigator for the study commented “EndoVigilant’s CADe application has the potential to decrease adenomas miss rates in colonoscopy and therefore, reduce the occurrence of interval colon cancers.”

EndoVigilant, Inc., a privately held company developing an artificial intelligence (AI) enabled medical imaging platform for endoscopy procedures announced that the pivotal clinical study for its first application using the platform is now in progress at multiple sites across the US. The first application focuses on real-time computer aided detection (CADe) assistance for improving polyp detection during colonoscopies.

Colonoscopy is a gold standard screening test for screening of colon cancer, which continues to be one of the leading causes of cancer related deaths in the US. Even though approximately 18 million colonoscopy procedures are performed annually in the US, adenomatous polyp miss rate as high as 26% often results in missed cancers.

EndoVigilant’s first application has been developed to assist gastroenterologists in real-time with polyp detection with the goal of reducing adenomatous polyp miss rate and hence, the occurrence of interval colon cancers. EndoVigilant’s software has been developed using state of the art deep learning AI algorithms and is trained on images and videos collected from practicing gastroenterologists from multiple academic and private endoscopy centers across the US. It is interoperable with existing endoscopy systems and can be deployed in a plug-and-play manner without requiring changes or costly upgrades to those systems.

Earlier this year, EndoVigilant reached an agreement with the FDA on the design of its pivotal clinical study. The study is a prospective, multi-center, randomized controlled trial with sites and investigators from both academic and community settings. The study is currently being performed to support the company’s planned filing to the FDA to obtain market clearance in the US.

Dr. Shai Friedland, Professor of Medicine at Stanford University, the Principal Investigator for the study commented “AI is a rapidly growing field with multiple medical applications in gastrointestinal endoscopy. EndoVigilant’s CADe application for colonoscopy procedures has the potential to improve polyp detection rates, decrease adenomas miss rates in colonoscopy and therefore, reduce the occurrence of interval colon cancers.”

“The progress of clinical pivotal study highlights our commitment to demonstrate the clinical benefits of EndoVigilant’s CADe application and getting it in the hands of gastroenterologists as soon as possible,” stated Vineet Sachdev, CEO and Co-Founder of EndoVigilant. “Based on strong results from pilot studies earlier, we are confident that this pivotal study will show increased adenomatous polyp detection without introducing significant risk when our software is used by gastroenterologists while performing colonoscopy procedures. We expect the pivotal clinical study to complete in Q1 2021.”

About EndoVigilant

Headquartered in Maryland, home to one of the largest life sciences clusters in the US, EndoVigilant, Inc., is a privately-held company developing an AI enabled medical imaging platform for endoscopy procedures. The platform’s first application is focused on improving colon polyp detection during colonoscopies with additional applications planned for the entire digestive tract. For more information, please visit http://www.endovigilant.com .

Share article on social media or email:

RADLogics Announces New Advancements and Research in AI-Powered COVID-19 Medical Imaging Solutions


RADLogics

With the U.S. in the midst of an unprecedented rise in COVID-19 infections, with current hospitalizations at an all-time record of more than 90,000 patients, there is an increasing need for AI solutions in medical imaging, said Moshe Becker, CEO and Co-Founder of RADLogics

RADLogics™ today announced the availability of the latest version of the company’s AI-Powered COVID-19 CT algorithm. Building on the company’s AI-Powered solution that has processed and analyzed hundreds of thousands of suspected Coronavirus cases globally, the latest update delivers a complex deep learning system consisting of several models utilized to detect, localize and segment regions in the lungs infected with COVID-19. With Coronavirus cases again surging across the U.S. along with hospitalizations, AI-Powered solutions are poised to not only alleviate the increased burden associated with COVID-19, but to help support improved outcomes by reducing burnout and errors.

As part of RADLogics’ latest version of its algorithm, three different analyses can now be performed simultaneously on raw chest CT image scans including: 1) a lungs region-of-interest are cropped with lung abnormalities detected; 2) the lung lobes are segmented and; 3) if the nodules plug-in is activated, focal Ground Glass Opacities (GGOs) are detected. According to leading physicians, these measurements are key features in determining patient classification into COVID-19 and non-COVID-19 indications. The overall system produces the decision whether the case is suspected for COVID-19 with a confidence level (in percentages). These measurements along with other features are used by radiologists to distinguish between COVID-19 and other abnormalities such as common pneumonia.

“With the U.S. in the midst of an unprecedented rise in COVID-19 infections, with current hospitalizations at an all-time record of more than 90,000 patients, there is an increasing need for AI solutions in medical imaging,” said Moshe Becker, CEO and Co-Founder of RADLogics. “Coronavirus-related infection rates are experiencing a sharp increase in most states – from rural communities to urban areas – that have the potential to overwhelm ER, ICU and radiology teams with a surge of patients, and AI-Powered medical imaging analysis solutions are poised to reduce this pressure through improved patient triage, monitoring and management.”

Since the pandemic started earlier this year, RADLogics has responded with the deployment of the company’s AI-Powered medical image analysis solution worldwide. In accordance with FDA guidance for imaging systems and software to address the COVID-19 public health emergency, RADLogics has made its FDA cleared CT and X-ray solutions available to hospitals and healthcare systems throughout the U.S. for patient triage and management. Designed for easy installation and integration both on-site and via the cloud, RADLogics’ algorithms are supported by the company’s patented software platform that enables rapid deployment at multiple hospitals, and seamless integration with existing workflows. All of the company’s AI-Powered solutions are available worldwide through major OEM distribution partners including Nuance via the AI Marketplace in the U.S. market.

To further validate the ability of AI to distinguish COVID-19 from other respiratory diseases, the company also highlighted a new research paper in preprint entitled “Automated triage of COVID-19 from various lung abnormalities using chest CT features”. Led by Professor Hayit Greenspan from Tel Aviv University and members of the RADLogics’ algorithm development team, the paper studied a fully automated AI-based system that takes as input chest CT scans and triages COVID-19 cases.

The study explored multiple descriptive features, including lung and infections statistics, texture, shape and location, to train a machine learning based classifier that distinguishes between COVID-19 and other lung abnormalities (including community acquired pneumonia). The research evaluated the system on a dataset of 2,191 CT cases and demonstrated a robust outcome with 90.8 percent sensitivity at 85.4 percent specificity with 94.0 percent ROC-AUC. Results of this study are available on arXiv.org, and it has been submitted for review and potential publication.

RADLogics will be featured this week as part of the RSNA 2020 Imaging AI in Practice demonstration. In addition, RADLogics will be included in the Nuance virtual booth as part of the company’s AI Marketplace display. You can also learn more about RADLogics’ COVID-19 solutions on the company’s website at https://www.radlogics.com/covid-19.

About RADLogics

RADLogics is a healthcare software company developing AI-Powered solutions that support image analysis to improve radiologists’ productivity while enhancing patient outcomes. Based in New York, NY, U.S., and Tel Aviv, Israel, RADLogics is one of the pioneers in using AI & machine learning image analysis and advanced big data analytics to search and analyze imaging data from CTs, MRIs, PET scans, and X-rays to help reduce diagnostics turnaround time from hours to minutes by automating detection and report generation functions. The company’s patented AI medical image analysis platform enables rapid development of AI algorithms, and provides seamless integration into existing radiology workflow. Visit http://www.radlogics.com to learn more or follow us on LinkedIn or Twitter. To contact RADLogics to request a demonstration or to sign up for our monthly newsletter, please visit https://www.radlogics.com/contact.

###

Share article on social media or email: